{"disease":{"id":"fgfr2-gene-amplification","name":"fgfr2 gene amplification"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04096417","title":"Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":14,"lead_sponsor_name":"Academic and Community Cancer Research United","has_results":true},{"nct_id":"NCT05052372","title":"Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib","phase":"","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"xCures","has_results":false},{"nct_id":"NCT02706691","title":"BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"University of Chicago","has_results":true}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}